Description
FOXO4-DRI (or Proxofim) is a research peptide designed to eliminate senescent cells—cells that stop dividing but cause inflammation (SASP) and accelerate aging—by inhibiting the interaction between FOXO4 and p53. By disrupting this interaction, it forces senescent cells to undergo apoptosis (programmed cell death)





Reviews
There are no reviews yet.